Literature DB >> 8131792

Chlamydia pneumoniae, strain TWAR and atherosclerosis.

J T Grayston1, C C Kuo, L A Campbell, E P Benditt.   

Abstract

Infection with Chlamydia pneumoniae, strain TWAR, has been associated with atherosclerotic cardiovascular disease in two types of investigations, seroepidemiological and morphological-molecular. A series of seroepidemiological studies from Finland and the United States have shown a statistically significant association between several types of TWAR antibody, including immune complexes, and atherosclerotic disease of the coronary and carotid arteries. The morphological-molecular studies have shown the C. pneumoniae organism in atheroma of the coronary arteries, and aorta but not in normal arteries. The presence of the organism in atheroma has been demonstrated by electron-microscopy, immunocytochemical staining with TWAR-specific monoclonal antibody and by the polymerase chain reaction for TWAR-specific DNA. The aetiological or pathogenic significance of the association of C. pneumoniae and atherosclerotic disease remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8131792

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  17 in total

Review 1.  Chlamydia pneumoniae and atherosclerosis.

Authors:  J D Rutherford
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

2.  Genomic rearrangements on VCAM1, SELE, APEG1and AIF1 loci in atherosclerosis.

Authors:  D A Arvanitis; G A Flouris; D A Spandidos
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

3.  Chlamydia pneumoniae infected macrophages exhibit enhanced plasma membrane fluidity and show increased adherence to endothelial cells.

Authors:  Anthony A Azenabor; Godwin Job; Olanrewaju O Adedokun
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

4.  Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals.

Authors:  A Schumacher; A B Lerkerød; I Seljeflot; L Sommervoll; I Holme; J E Otterstad; H Arnesen
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

5.  Atherosclerosis due to chronic arteritis caused by Chlamydia pneumoniae: a tentative hypothesis.

Authors:  W Stille; R Dittmann; G Just-Nübling
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 3.553

6.  Imaging of atherosclerosis--a worthy challenge.

Authors:  H W Strauss
Journal:  J Nucl Cardiol       Date:  1996 May-Jun       Impact factor: 5.952

Review 7.  Chronic infections and atherosclerosis/thrombosis.

Authors:  Prediman K Shah
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

8.  Evidence for numerous omp1 alleles of porcine Chlamydia trachomatis and novel chlamydial species obtained by PCR.

Authors:  B Kaltenböck; N Schmeer; R Schneider
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

Review 9.  Chlamydia pneumoniae: defining the clinical spectrum of infection requires precise laboratory diagnosis.

Authors:  S J Bourke; N F Lightfoot
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

10.  Elicitation of reactive oxygen species in Chlamydia pneumoniae-stimulated macrophages: a Ca2+-dependent process involving simultaneous activation of NADPH oxidase and cytochrome oxidase genes.

Authors:  Anthony A Azenabor; Shoua Yang; Godwin Job; Olanrewaju O Adedokun
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.